EUVIMEDEUVIMED entdecken
Crossref

Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism

Matthias Büttner, Gerasimos Sykiotis, Akram Al-Ibraheem, Monica Pinto, Ioannis Iakovou, Arild Andre Østhus, Eva Hammerlid, Laura Deborah Locati, Eva Maria Gamper, Juan Ignacio Arraras, Susan J Jordan, Naomi Kiyota und 12 weitere

Hormones · 2025

DOI: 10.1007/s42000-025-00654-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormones, 2025. Verfasst von Matthias Büttner und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre Mainz, Mainz, Germany. matbuett@uni-mainz.de. Hauptthemen laut MEDLINE: Hypoparathyroidism, Quality of Life, Thyroid Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Hypoparathyroidism (HypoPT) is one of the most common complications of surgical treatment for thyroid cancer and afflicated patients often report symptoms or impairments in quality of life (QoL). We aimed to investigate differences in various QoL domains between thyroid cancer survivors with and without permanent hypoparathyroidism. METHODS: Thyroid cancer survivors with a minimum of 1.5 years post-diagnosis completed the EORTC core questionnaire (EORTC QLQ-C30) and the EORTC thyroid module (QLQ-THY34). Sociodemographic and clinical information were obtained from the patients themselves and their medical charts. Analysis of covariance was used to compare QoL between survivors with and without hypoparathyroidism (adjusting for age, gender, time since diagnosis, and comorbidity). RESULTS: Of the 126 participants, 21 (17%) were diagnosed with permanent HypoPT. There was no evidence of differences regarding any QoL domain between survivors due to hypoparathyroidism. The symptoms with the highest burden for both groups were fatigue (hypoPT: 24.9; non-hypoPT: 32.8; p = 0.151) and insomnia (hypoPT: 22.2; non-hypoPT: 30.8; p = 0.213). Thyroid cancer specific impairments were observed for joint pain (hypoPT: 28.6; non-hypoPT: 34.0; p = 0.480), worry about important others (hypoPT: 25.8; non-hypoPT: 27.9; p = 0.765), exhaustion (hypoPT: 23.8; non-hypoPT: 27.9; p = 0.482), and lacking social support (hypoPT: 36.5; no-hypoPT: 23.0; p = 0.070). CONCLUSION: The present study appears to show that QoL in thyroid cancer survivors may be unrelated to hypoparathyroidism, further suggesting a more complex relationship between these two aspects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoparathyroidismQuality of LifeThyroid NeoplasmsCancer SurvivorsHumansFemaleMaleMiddle AgedAgedAdultSurveys and Questionnaires

Stichwörter der Autor:innen

HypoparathyroidismQuality of lifeSurvivorsThyroid cancer

Autor:innen und Institutionen

  • Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre Mainz, Mainz, Germany. matbuett@uni-mainz.de.
  • Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), Division of Epidemiology and Health Services Research, University Medical Center Mainz, Rhabanusstr. 3, 55118, Mainz, Germany. matbuett@uni-main…
  • Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Rehabilitation Medicine Unit, Strategic Health Services Department, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Naples, Italy.
  • Department of Nuclear Medicine, Aristotle University, Thessaloniki, Greece.

Zitieren

APA

Büttner, M., Sykiotis, G., Al-Ibraheem, A., Pinto, M., Iakovou, I., Østhus, A. A., Hammerlid, E., Locati, L. D., Gamper, E. M., Arraras, J. I., Jordan, S. J., Kiyota, N., Engesser, D., Taylor, K., Canotilho, R., Ioannidis, G., Husson, O., Gama, R. R., Fanetti, G., …, & Singer, S. (2025). Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism. Hormones. https://doi.org/10.1007/s42000-025-00654-2

Vancouver

Büttner M, Sykiotis G, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, et al. Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism. Hormones. 2025. doi:10.1007/s42000-025-00654-2

BibTeX
@article{Bttner2025,
  author = {Büttner, Matthias and Sykiotis, Gerasimos and Al-Ibraheem, Akram and Pinto, Monica and Iakovou, Ioannis and Østhus, Arild Andre and Hammerlid, Eva and Locati, Laura Deborah and Gamper, Eva Maria and Arraras, Juan Ignacio and Jordan, Susan J and Kiyota, Naomi and Engesser, Deborah and Taylor, Katherine and Canotilho, Rita and Ioannidis, Georgios and Husson, Olga and Gama, Ricardo Ribeiro and Fanetti, Giuseppe and Moss, Laura and Inhestern, Johanna and Andry, Guy and Rimmele, Harald and Singer, Susanne},
  title = {Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism},
  journal = {Hormones},
  year = {2025},
  doi = {10.1007/s42000-025-00654-2}
}
Kostenlos starten →